Morgan Stanley’s Kezar Life Sciences KZR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $39.8K | Buy |
|
|||||
|
2025
Q1 | $35.2K | Sell |
|
|||||
|
2024
Q4 | $138K | Sell |
|
|||||
|
2024
Q3 | $172K | Buy |
|
|||||
|
2024
Q2 | $4.28K | Sell |
|
|||||
|
2024
Q1 | $91.2K | Sell |
|
|||||
|
2023
Q4 | $491K | Buy |
|
|||||
|
2023
Q3 | $160K | Sell |
|
|||||
|
2023
Q2 | $1.2M | Buy |
|
|||||
|
2023
Q1 | $585K | Buy |
|
|||||
|
2022
Q4 | $1.15M | Buy |
|
|||||
|
2022
Q3 | $1.21M | Sell |
|
|||||
|
2022
Q2 | $1.31M | Sell |
|
|||||
|
2022
Q1 | $8.89M | Sell |
|
|||||
|
2021
Q4 | $24.1M | Buy |
|
|||||
|
2021
Q3 | $10.5M | Sell |
|
|||||
|
2021
Q2 | $8.58M | Buy |
|
|||||
|
2021
Q1 | $76K | Sell |
|
|||||
|
2020
Q4 | $177K | Buy |
|
|||||
|
2020
Q3 | $59K | Sell |
|
|||||
|
2020
Q2 | $122K | Buy |
|
|||||
|
2020
Q1 | $13K | Sell |
|
|||||
|
2019
Q4 | $120K | Buy |
|
|||||
|
2019
Q3 | $21K | Sell |
|
|||||
|
2019
Q2 | $578K | Buy |
|
|||||
|
2019
Q1 | $130K | Sell |
|
|||||
|
2018
Q4 | $436K | Buy |
|
|||||
|
2018
Q3 | $243K | Buy |
|